Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Skilled Recruitment Solutions GmbH seeks a Senior Manager, GCP Inspection Lead to join a fast-paced biopharmaceutical environment in Basel. You will own frontline defense and preparation for global health authority audits, reporting to the Senior Director
Are you a seasoned GCP Quality Assurance expert who thrives when leading high-stakes health authority inspections? Do you possess the diplomacy, resilience, and operational sharpness to step directly into a fast-paced, live-inspection environment? We are partnering
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
Revolution Medicines is seeking a Director, Regulatory Affairs, Europe to lead regulatory strategy and execution for EU/EEA/UK/Switzerland oncology programs. You will drive MAA filings, lifecycle management, and proactive engagement with EMA, MHRA and Swissmedic, guiding cross‑functional teams
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‐addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)